NY-AQARA
23.11.2021 09:02:36 CET | Business Wire | Press release
Aqara, a leading provider of smart home products, announced today the launch of its next-gen flagship home security camera, the Camera Hub G3. The new camera is a 2K, pan-and-tilt camera with the local facial and gesture recognition features, and it integrates a built-in Zigbee 3.0 hub, allowing the device to connect up to 128 Aqara accessories*. It is now available on the Aqara Amazon brand stores in the US , Canada and France , and is also expected to be sold by authorized Aqara retailers in North America, Europe and Asia in the following weeks**.
Thanks to a powerful NPU-equipped processor, the Aqara Camera Hub G3 supports facial recognition and gesture recognition features, both of which can be used to trigger home automations. Users can configure to receive push notifications when their young kids arrive home or when a stranger is detected (i.e. a familiar face was not detected), or to stop video recording when the face of a family member or a preset hand gesture is recognized. The AI-enabled features will make homes safer, and make people’s lives even easier as users can now trigger home automation with certain hand gestures or simply a recognized face.
The G3 camera hub also supports automatic cruising, face tracking as well as pet tracking, all enabled by the 110° wide-angle lens and the pan-and-tilt motor which provides up to 340° rotation angle. The pan-and-tilt motor can be controlled manually, by the preset cruising path, or via home automations (for example, to turn to the front door when Door & Window Sensor is triggered). Combined with the high-resolution 2304×1296 pixel sensor and the infrared night vision enabled by the 940 nm LEDs, which are invisible at night, the G3 protects homes in 360-degree with no blind spot, day and night.
Compared to the previous G2H Camera Hub, the new G3 provides other advanced features including:
- Wider compatibility with third-party platforms : as a camera it supports not only HomeKit Secure Video*** but also streaming to Amazon Alexa and Google Assistant smart displays, while as a hub it allows connected child devices to support a wide range of third-party ecosystems and voice assistants, such as HomeKit, Alexa, Google Home, IFTTT, and more;
- Local infrared control : the built-in IR controller allows the G3 to automate the infrared-compatible devices, and the IR automation is local which means it remains functioning without the Internet connection;
- Dual-band Wi-Fi support : both 2.4GHz and 5GHz Wi-Fi networks are supported;
- Privacy protection : it is equipped with a privacy shutter that physically covers the camera lens, and the shutter can be activated manually and automatically;
- Type-C port with video out : it uses the modern and universal connector that supports low-latency, high-definition video output via UVC protocol.
To celebrate the launch, Aqara is now offering limited-time discounts for the new Camera Hub G3 on its Amazon brand stores. North American customers will enjoy a 20% discount at check with the promo code USG3PRGE in the US and Canada , and the code will be valid through Nov 24, 2021. Aqara also offers French customers a 20€ OFF discount at its Amazon.fr store , with the promo code CAMERAG3FR, and the offering will expire on Nov 25, 2021.
For more details of the G3 camera hub, please visit our website .
* To connect up to 128 devices, Zigbee routers/repeaters such as Smart Wall Switch (With Neutral) and Smart Plug are required.
** Product availability may vary among different retail channels, and could be updated all the time. It’s recommended to check with the regional retailer(s) for real time availability.
*** In HomeKit Secure Video mode, the camera records in Full HD 1080p and Pan/Tilt controls are not available due to the current limitations of HomeKit technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123005627/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
